- Home
- PEPG vs CEE Comparison
PEPG vs CEE Comparison
Compare PEPG & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- CEE
- Stock Information
- Founded
- PEPG 2018
- CEE 1990
- Country
- PEPG United States
- CEE Germany
- Employees
- PEPG N/A
- CEE N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- PEPG Health Care
- CEE Finance
- Exchange
- PEPG Nasdaq
- CEE Nasdaq
- Market Cap
- PEPG 64.2M
- CEE 72.9M
- IPO Year
- PEPG 2022
- CEE N/A
- Fundamental
- Price
- PEPG $1.37
- CEE $13.82
- Analyst Decision
- PEPG Buy
- CEE
- Analyst Count
- PEPG 3
- CEE 0
- Target Price
- PEPG $14.67
- CEE N/A
- AVG Volume (30 Days)
- PEPG 486.5K
- CEE 22.0K
- Earning Date
- PEPG 03-05-2025
- CEE 01-01-0001
- Dividend Yield
- PEPG N/A
- CEE 3.86%
- EPS Growth
- PEPG N/A
- CEE N/A
- EPS
- PEPG N/A
- CEE N/A
- Revenue
- PEPG N/A
- CEE N/A
- Revenue This Year
- PEPG N/A
- CEE N/A
- Revenue Next Year
- PEPG N/A
- CEE N/A
- P/E Ratio
- PEPG N/A
- CEE N/A
- Revenue Growth
- PEPG N/A
- CEE N/A
- 52 Week Low
- PEPG $1.16
- CEE $7.80
- 52 Week High
- PEPG $19.30
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- PEPG 31.82
- CEE 74.56
- Support Level
- PEPG $1.16
- CEE $15.01
- Resistance Level
- PEPG $1.60
- CEE $16.71
- Average True Range (ATR)
- PEPG 0.14
- CEE 0.70
- MACD
- PEPG 0.11
- CEE 0.16
- Stochastic Oscillator
- PEPG 48.28
- CEE 66.26
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.